Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
Simone I. Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 880-886.e4
Open Access | Times Cited: 105

Showing 51-75 of 105 citing articles:

Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Andrew P. Hederman, Harini Natarajan, Leo Heyndríckx, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern
Monika Kumari, Kang-Hao Liang, Shih-Chieh Su, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 714-714
Open Access | Times Cited: 2
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response
Claire Butters, Ntombi Benede, Thandeka Moyo-Gwete, et al.
Clinical Immunology (2023) Vol. 259, pp. 109877-109877
Open Access | Times Cited: 6
The Omicron-transformer: Rise of the subvariants in the age of vaccines
Travis Ren Teen Chia, Barnaby Edward Young, Po Ying Chia
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 11, pp. 712-729
Open Access | Times Cited: 10
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH)
Giulia Lamacchia, Lorenzo Salvati, Seble Tekle Kiros, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3261-3261
Open Access | Times Cited: 10
Antibody‐dependent NK‐cell and neutralizing antibody responses against the Spike protein of Wuhan‐Hu‐1 and Omicron BA.1 SARS‐CoV‐2 variants in vaccinated experienced and vaccinated naïve individuals
Eliseo Albert, Daniel Fernández‐Soto, Estela Giménez, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 5
Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Isabella Zanella, Melania Degli Antoni, Valentina Marchese, et al.
International Immunopharmacology (2022) Vol. 110, pp. 108943-108943
Open Access | Times Cited: 9
SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines
Hadeel T. Zedan, Maria K. Smatti, Duaa W. Al‐Sadeq, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination
Ángela Sánchez‐Simarro, Daniel Fernández‐Soto, Brayan Grau, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity
Simone I. Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Closed Access | Times Cited: 1
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals
Anna Offersgaard, Carlos R. Duarte Hernandez, Yuyong Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease
Sarah E. Frampton, Rosanna Smith, Lili Ferson, et al.
Immunological Reviews (2024)
Open Access | Times Cited: 1
Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern
Jinal N. Bhiman, Penny L. Moore
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 61-75
Open Access | Times Cited: 8
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
Adrian Rice, Mohit S. Verma, Emily A. Voigt, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Intravenous Human Immunoglobulins Neutralizes Omicron Subvariants BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/BA.5 for Treatment of Coronavirus Disease 2019
Mayanka Awasthi, Hana Golding, Surender Khurana
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e503-e506
Open Access | Times Cited: 8
Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
Huiyun Peng, Tianxin Xiang, Fei Xu, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 940-940
Open Access | Times Cited: 4
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
Cristina Capuano, Davide De Federicis, Daniel Ciuti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design
Blake M. Hauser, Jared Feldman, Maya Sangesland, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100834-100834
Open Access | Times Cited: 7
Human primary Omicron BA.1 and BA.2 infections result in sub-lineage-specific neutralization
Karin Stiasny, Iris Medits, David Niklas Springer, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 6
SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1
Simone I. Richardson, Thopisang Motlou, Mieke A. van der Mescht, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations
Andrew P. Hederman, Harini Natarajan, Joshua A. Wiener, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
Yuwei Zhang, Shanshan Han, Xingyu Guo, et al.
Journal of Infection (2022) Vol. 86, Iss. 2, pp. e40-e42
Open Access | Times Cited: 6
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6

Scroll to top